
Eight areas of improvement were developed as part of national initiative with stakeholder involvement.

Eight areas of improvement were developed as part of national initiative with stakeholder involvement.

In survivors of lymphoma with fragmented transition of care, preparedness and activation for the next phase of their survivorship was lacking.

Pharmacists play a crucial role in supporting patients with HR+/HER2– breast cancer.

Community pharmacists can participate in continuing education epilepsy programs, but they are usually not specific to pharmacy practice.

Examples include reviewing antibiotic doses, identifying drug-drug interactions, and implementing fall prevention strategies.

Pharmacists can play a crucial role in educating patients on the proper storage and administration of evolocumab.

Previously, the device was indicated for the management of type 1 diabetes in patients aged 2 years and older.

Accurate, effective screening is crucial for connecting patients with needed financial resources and support.

Despite evidence supporting the benefit of placing pharmacists in the ICU, there is still reluctance to widely adopt decentralized pharmacist models, largely due to immediate cost concerns and underrepresentation of pharmacy leaders in decision-making roles.

For pharmacies, AI and other technologies are key to thriving in the era of value-based care.

Pegcetacoplan is a targeted C3 therapy that is intended to regulate excessive activation of the complement cascade.

With diagnostic tools, oncology pharmacists and other health care providers can help to identify treatments that have the best probability of working for a specific patient.

Medication therapy management reimbursement can be a driving factor to work toward statin implementation in this patient group.

Pharmacists have been shown to contribute to improved adherence rates, therapy optimization, patient safety, and cost-savings.

The indication is for adults with relapsed or refractory chronic lymphocytic leukemia or small lymphocytic lymphoma who were treated with at least 2 prior lines of therapy.

The guidance, if finalized, would revise considerations about switching studies for proposed interchangeable biosimilars.

Clinical improvements for patients with diabetes seen in a collaboration between the University of North Carolina and Blue Cross and Blue Shield of North Carolina.

Patients can face barriers to BCMA-targeted treatments.

Inflammatory conditions such as celiac disease can require care consideration and monitoring to manage iron deficiency

Pediatric patients weighing 20 kg to <50 kg should take 20 mg of apremilast twice daily and children weighing at least 50 kg should take 30 mg twice daily.

In an initiative to close vaccine gaps in local Missouri communities, pharmacists and community health workers proved essential.

Aligning with previous data, the drug combination was modestly effective in patients with large B-cell lymphoma pre- and post-CAR-T-cell therapy.

Pharmacists can be essential sources of education for patients, offering them guidance on safe use and proper dosage.

The financial burden has increased significantly since 2015.

Building trust between techs and patients makes administering vaccines easier and increase immunizers’ confidence.

For adults receiving the 15 mg dose, tirzepatide sustained weight loss with an average reduction of 22.9% in body weight compared with 2.1% for the placebo.

Let’s shine the spotlight on ourselves, and let’s begin to heal.

In Finland, season of birth, notably autumn and winter, was associated with the development of asthma and allergic rhinitis.

The proposed diagnostic agent has a long half-life, enables imaging the next day, and correlates to a longer shelf life in the pharmacy.

In Missouri, community health workers partnered with community pharmacists, CPESN, and others to develop a state-funded program to address vaccine gaps in local communities.